FOLH1 and prostate cancer: More recently, preclinical studies with [149Tb]Tb-DOTANOC and [149Tb]Tb-PSMA-617 were reported in tumor xenograft mouse models of AR42J pancreatic and prostate cancers, respectively [168,172].